Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AVODART
- Phase II Dutasteride in Combination With CAB vs CAB in SDC
- Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
- To Evaluate the Pharmacokinetics and Safety of AD-208
- Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy
- Safety and Pharmacokinetic Characteristics of DKF-313
- ITT-5 Mechanisms of Spermatogenesis in Man
- Dutasteride Treatment for the Reduction of Heavy Drinking in Men
- Bioequivalence - Duodart Against Avodart & Omnic
- Response of Patients on Surveillance for Prostate Cancer to Dutasteride
- A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in
- Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.
- Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
- STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling
- Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
- AVODART(Dutasteride) Post-marketing Surveillance(PMS)
- Dutasteride for the Reduction of Alcohol Use in Male Drinkers
- A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-
- ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
- Dutasteride in Treating Patients With Prostate Cancer
- AVODART® Alopecia Post-marketing Surveillance (PMS)
- Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer
- Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
- Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
- Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
- Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
- Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
- Pharmacogenetics of Alcohol: Treatment Implications
- MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
- A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart
- Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
- ARTS - AVODART After Radical Therapy For Prostate Cancer Study
- A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
- PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
- Oral Androgens in Man-4: (Short Title: Oral T-4)
- Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)
- Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
- Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
- Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
- Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
Clinical trials list
click for details